Lv11
50 积分 2025-01-24 加入
Ⅰ期临床试验中健康参与者安全性管理的专家共识
6小时前
待确认
Toxicity and response criteria of the Eastern Cooperative Oncology Group
3个月前
已完结
Toxicity and response criteria of the Eastern Cooperative Oncology Group
3个月前
已完结
Rethinking Risk-Benefit Assessment for Phase I Cancer Trials
3个月前
已关闭
New Adaptive Method for Phase I Trials in Oncology
3个月前
已完结
Rethinking Risk-Benefit Assessment for Phase I Cancer Trials
3个月前
已关闭
A review of dose-limiting events in phase I trials: antimetabolites show unpredictable relationships between dose and toxicity
3个月前
已完结
Planung und Durchführung klinischer Phase-I-Studien
3个月前
已完结
皖公网安备34019202002308
